相关实验视频

Updated: Jun 5, 2025

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

POSTN对瘤细胞行为和肺腺癌瘤中瘤微环境的影响

Dongfeng Sun¹, Jie Lu¹, Hui Tian²

¹Department of Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital Affiliated to Shandong First Medical University, Shandong Academy of Medical Science, Jinan, Shandong, China.

International immunopharmacology

|December 13, 2024

概括

这项研究揭示,质素 (POSTN) 驱动肺腺癌的进展和免疫抑制. 阻断POSTN通过促进抗瘤免疫力来提高免疫疗法的有效性,为肺腺癌提供了一种新的治疗策略.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
基因组学就是基因组学.

背景情况:

癌症相关纤维细胞 (CAFs) 在肺腺癌 (LUAD) 免疫调节中的作用由于CAF异质性,尚不清楚.
了解CAF与瘤细胞的相互作用对于提高LUAD免疫疗法的有效性至关重要.

研究的目的:

为了分类LUAD瘤细胞和CAF,并分析它们的空间相互作用.
开发和验证基于肌纤维细胞特定基因的预后特征.
调查皮奥斯 (POSTN) 在LUAD进展和免疫逃避中的作用及其作为治疗点的潜力.

主要方法:

单细胞RNA测序和CSOmap用于细胞分类和空间重建.
一个预后基因签名的开发和验证.
在体内 (小鼠模型) 和体外 (细胞系) 实验中评估POSTN的功能和POSTN通路阻塞与PD-L1抑制相结合的疗效.

主要成果:

确定了具有特定肌纤维细胞相互作用的独特瘤细胞子集;肌纤维细胞特异性基因特征,包括POSTN,预测了LUAD预后.
高POSTN表达与糟糕的结果相关,促进瘤侵入性,EMT和M2巨细胞通过ITGB3.3的两极分化.
阻断与PD-L1抑制剂协同作用的POSTN通路,抑制瘤生长并增强抗瘤免疫力 (增加CD8+T细胞,M1/M2比率转移).

结论:

皮洛斯 (POSTN) 通过促进EMT,抑制细胞灭绝和操纵瘤微环境 (TME) 以免疫抑制为目的,在LUAD进展中发挥着关键作用.
向POSTN通路代表了一种有希望的策略,以提高肺腺癌免疫治疗的疗效.

关键词:

免疫治疗是一种免疫疗法.肺部腺癌瘤是肺部腺癌.巨细胞的两极分化肌纤维细胞细胞.这里是POSTNN.

更多相关视频

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...